Common Types of Primary Antibodies and Strategies for Optimizing Their Storage Stability

Main Types of Primary Antibodies and Technical Differences

Primary antibodies can be classified by preparation method into polyclonal antibodies, monoclonal antibodies, and recombinant antibodies. Polyclonal primary antibodies are derived from multiple B cell clones and can recognize multiple epitopes of an antigen, potentially offering higher overall binding capacity when the antigen conformation is complex or abundance is low; monoclonal primary antibodies have higher specificity and relatively stable batch-to-batch performance; recombinant primary antibodies are obtained through genetic engineering expression, with controllable sequences and production conditions, making them suitable for long-term supply and quality standardization.

Storage Factors Affecting Primary Antibody Activity

The activity of primary antibodies is affected by temperature, freeze-thaw cycles, buffer composition, and antibody concentration. High-concentration antibodies are generally more stable than very dilute solutions, so aliquoting according to usage amount is recommended for storage. Repeated freeze-thaw cycles may cause protein aggregation or decreased activity and should be avoided as much as possible. A common practice is to aliquot primary antibodies and store them at -20°C or -80°C, retrieving a single aliquot when needed.

Common Choices of Buffer Systems and Additives

Primary antibody storage solutions generally contain phosphate or Tris buffer systems, with appropriate amounts of protein stabilizers, glycerol, or preservatives added. Different additives interfere differently with downstream experiments; for example, sodium azide may affect certain cell experiments, so selection should be based on the specific application. During transport and short-term use, 2-8°C conditions may be suitable for certain primary antibodies containing stabilizers, but long-term storage still recommends low temperatures.

Stability Monitoring and Record-Keeping During Use

Laboratories can establish a primary antibody usage log, recording aliquot dates, freeze-thaw cycles, diluent types, and experimental results. For critical experiments, positive controls can be set up to monitor antibody activity. If signal weakening or abnormal background occurs, the first step should be to check whether storage conditions comply with the product instructions. Reasonable stability management helps extend the service life of primary antibodies and ensures the reproducibility of experimental data.